These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10865941)

  • 1. Characterization of iron uptake from transferrin by murine endothelial cells.
    Hallmann R; Savigni DL; Morgan EH; Baker E
    Endothelium; 2000; 7(2):135-47. PubMed ID: 10865941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake.
    Richardson DR; Baker E
    J Cell Physiol; 1994 Oct; 161(1):160-8. PubMed ID: 7929602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D; Ponka P; Baker E
    Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a mechanism of iron uptake by cells which is stimulated by hydroxyl radicals generated via the iron-catalysed Haber-Weiss reaction.
    Richardson DR; Ponka P
    Biochim Biophys Acta; 1995 Nov; 1269(2):105-14. PubMed ID: 7488642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of uptake of transferrin-bound iron by human hepatoma cells by nontransferrin-bound iron.
    Trinder D; Morgan E
    Hepatology; 1997 Sep; 26(3):691-8. PubMed ID: 9303500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process.
    Richardson DR
    Biochim Biophys Acta; 1997 May; 1320(1):45-57. PubMed ID: 9186779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin-bound and transferrin free iron uptake by cultured rat astrocytes.
    Qian ZM; Liao QK; To Y; Ke Y; Tsoi YK; Wang GF; Ho KP
    Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):541-8. PubMed ID: 10872741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR; Milnes K
    Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrogen monoxide decreases iron uptake from transferrin but does not mobilise iron from prelabelled neoplastic cells.
    Richardson DR; Neumannova V; Ponka P
    Biochim Biophys Acta; 1995 May; 1266(3):250-60. PubMed ID: 7766711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferrin receptor-dependent and -independent iron transport in gallium-resistant human lymphoid leukemic cells.
    Chitambar CR; Wereley JP
    Blood; 1998 Jun; 91(12):4686-93. PubMed ID: 9616166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ceruloplasmin and ascorbate in cellular iron release.
    Richardson DR
    J Lab Clin Med; 1999 Nov; 134(5):454-65. PubMed ID: 10560938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.
    Richardson DR; Ponka P
    Biochim Biophys Acta; 1997 Mar; 1331(1):1-40. PubMed ID: 9325434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake.
    Wardrop SL; Richardson DR
    Eur J Biochem; 1999 Jul; 263(1):41-9. PubMed ID: 10429185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial transcytosis of iron-transferrin in the liver does not involve endosomal traffic.
    Omoto E; Minguell JJ; Tavassoli M
    Pathobiology; 1992; 60(5):284-8. PubMed ID: 1472282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: implications for the pathogenesis of iron-overload disease.
    Richardson DR; Chua AC; Baker E
    J Lab Clin Med; 1999 Feb; 133(2):144-51. PubMed ID: 9989766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin-bound iron uptake by the cultured cerebellar granule cells.
    Qian ZM; Pu YM; Tang PL; Wang Q
    Neurosci Lett; 1998 Jul; 251(1):9-12. PubMed ID: 9714452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs.
    Becker E; Richardson DR
    J Lab Clin Med; 1999 Nov; 134(5):510-21. PubMed ID: 10560945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR; Tran EH; Ponka P
    Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.